GSK Plc ADR (NYSE: GSK) has a price-to-earnings ratio of 13.55x that is above its average ratio. Additionally, the 36-month beta value for GSK is
The stock of GSK Plc ADR (GSK) has seen a -0.86% decrease in the past week, with a -5.99% drop in the past month, and
GSK Plc ADR (NYSE: GSK) has a higher price-to-earnings ratio of 13.77x compared to its average ratio, The 36-month beta value for GSK is at
The price-to-earnings ratio for GSK Plc ADR (NYSE: GSK) is above average at 13.95x, Company’s 36-month beta value is 0.67.Analysts have differing opinions on the
GSK Plc ADR (NYSE: GSK)’s stock price has dropped by -0.09 in relation to previous closing price of 42.83. Nevertheless, the company has seen a
© 2024, Fueled by Smart TechOne
